Millennium Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-38,093
| Closed | -$149K | – | 7299 |
|
|
2023
Q3 | $149K | Buy |
+38,093
| New | +$260K | ﹤0.01% | 5222 |
|
|
2023
Q2 | – | Sell |
-2,921
| Closed | -$11K | – | 7463 |
|
|
2023
Q1 | $11K | Sell |
2,921
-1,771
| -38% | -$27.3K | ﹤0.01% | 6019 |
|
|
2022
Q4 | $151K | Sell |
4,692
-4,541
| -49% | -$180K | ﹤0.01% | 5437 |
|
|
2022
Q3 | $386K | Sell |
9,233
-424
| -4% | -$19.4K | ﹤0.01% | 5180 |
|
|
2022
Q2 | $408K | Buy |
9,657
+7,481
| +344% | +$347K | ﹤0.01% | 5116 |
|
|
2022
Q1 | $148K | Sell |
2,176
-3,247
| -60% | -$270K | ﹤0.01% | 5976 |
|
|
2021
Q4 | $658K | Buy |
5,423
+4,473
| +471% | +$755K | ﹤0.01% | 4802 |
|
|
2021
Q3 | $134K | Sell |
950
-1,577
| -62% | -$312K | ﹤0.01% | 6302 |
|
|
2021
Q2 | $694K | Sell |
2,527
-3,713
| -60% | -$937K | ﹤0.01% | 5001 |
|
|
2021
Q1 | $1.33M | Buy |
6,240
+4,245
| +213% | +$1.17M | ﹤0.01% | 3913 |
|
|
2020
Q4 | $482K | Sell |
1,995
-5,612
| -74% | -$694K | ﹤0.01% | 4227 |
|
|
2020
Q3 | $802 | Buy |
7,607
+6,321
| +492% | +$576K | ﹤0.01% | 3292 |
|
|
2020
Q2 | $126K | Buy |
1,286
+715
| +125% | +$62.6K | ﹤0.01% | 3946 |
|
|
2020
Q1 | $43K | Buy |
+571
| New | +$54.4K | ﹤0.01% | 3679 |
|
